
Innovative Research Facility Enhances Local Skills
The official opening of The Centre for Advanced Training and Innovative Research in Pretoria. Picture: supplied.
South Africa has bolstered its fight against future pandemics and disease with the launch of a new training facility for the next generation of scientists.
Thermo Fisher Scientific, South African Medical Research Council and Department of Science Innovation and Technology recently collaborated on the Centre for Advanced Training and Innovative Research (CATIR) in Pretoria.
The centre will offer training in advanced molecular science and laboratory management. This move will enhance essential scientific skill within South Africa.
The official opening of this training facility took place this week and will support future pandemic preparedness and local health system resilience.
It will bridge the gap between academic theory and practical application, equipping future scientists with the skills to lead research and healthcare advancements relevant to local needs.
ALSO READ: 'Renewed energy': New NYDA CEO gets to work as youth joblessness hits crisis point
Advancement of students
President and Chief Executive Officer at SAMRC, Professor Ntobeko Ntusi, said said the centre 'reflects the SAMRC's belief in the value of investing in the infrastructure and expertise that will help our country address local gaps in critical areas of science'.
The first cohort of 20 CATIR students is scheduled to be trained by the end of 2025. Once fully operational, the Centre will have the capacity to train up to 160 students annually, with courses lasting five weeks.
'The Covid-19 pandemic taught us that we needed to do more to build skills in clinical and molecular testing to improve the resilience of our health system against the diseases of today and tomorrow.
'The opening of this important new educational facility is a landmark moment in our journey to achieving this important goal,' said Professor Ntusi.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

TimesLIVE
7 hours ago
- TimesLIVE
Saving mothers, shaping policy: professor's fight for mothers
From Cape Town maternity wards to rural obstetric interventions and policy task rooms at the national department of health, Prof Susan Fawcus has played a key role in shaping South Africa's response to the preventable tragedy of mothers dying while giving birth. Seated at a table inside her Plumstead home, the former head of obstetric services at Cape Town's Mowbray Maternity Hospital from 1996 to 2018, reveals the harsh reality of maternal deaths in the country using figures from Saving Mothers reports. The reports, which Fawcus edited as a member of the National Committee on Confidential Enquiries into Maternal Deaths (NCCEMD), note that in 2019, maternal deaths fell below 100 per 100,000 live births for the first time, reaching 98.8. But in 2021 it spiked to 148 as Covid-19 disrupted services. Fawcus offers two reasons for the rise in maternal deaths during Covid. 'One, there were a lot of women who died from Covid pneumonia, usually in the later stages of pregnancy. So that was probably the biggest reason,' she says. 'And then the second reason was the effect on health services: emergency ambulances were being used for Covid, staff were off because they had Covid or they were in quarantine.' Behind each data point is a family ruptured by tragedy, Fawcus stresses. During the interview her speech is matter-of-fact as she cites figures, her tone soft-spoken and measured. But it is apparent that this stoic facade belies a deep passion for the plight of mothers suffering and dying preventable deaths during childbirth.

The Herald
3 days ago
- The Herald
Health department takes charge in quest for global TB vaccine in SA
If the clinical trials that are now under way succeed, the world may have a vaccine that can prevent tuberculosis (TB) in adults and adolescents within the next few years, says health minister Aaron Motsoaledi. Motsoaledi was giving the keynote address at a national workshop in Sandton on Wednesday on the creation of a TB vaccine for children and adults. 'This is a beginning of a new chapter where prevention of TB through vaccination will become the order of the day and a groundbreaking innovation,' Motsoaledi said. The workshop was hosted by the department of health in partnership with the World Health Organisation (WHO). 'For over 100 years, we have relied on the BCG vaccine to protect our children from TB. But we have not had a tool that can protect adolescents and adults', he said. Motsoaledi said the day when an announcement is made on the availability of the vaccine will be a revolutionary and would be like freedom from slavery for citizens. 'The slavery of poverty, which is exacerbated by tuberculosis, premature death of young adults, people losing jobs because of tuberculosis, will come to an end', he said. Motsoaledi emphasised that the key areas that will make the system ready for implementation and rollout of the vaccine will be generating evidence for policy and investments, reliable delivery systems, and production and supply of the TB vaccine. 'These new vaccines will be a game changer for prevention and for reducing the need for TB preventive treatment in health systems', he said. Motsoaledi said the advent of Covid-19 taught the world when urgency met preparation. 'We saw how vaccines could be developed, approved and distributed at record speed but we also learnt that science alone is not enough. Public trust, strong systems, clear communication and equitable access are just as essential,' Motsoaledi said. TimesLIVE

TimesLIVE
4 days ago
- TimesLIVE
Health department takes charge in quest for global TB vaccine in SA
If the clinical trials that are now under way succeed, the world may have a vaccine that can prevent tuberculosis (TB) in adults and adolescents within the next few years, says health minister Aaron Motsoaledi. Motsoaledi was giving the keynote address at a national workshop in Sandton on Wednesday on the creation of a TB vaccine for children and adults. 'This is a beginning of a new chapter where prevention of TB through vaccination will become the order of the day and a groundbreaking innovation,' Motsoaledi said. The workshop was hosted by the department of health in partnership with the World Health Organisation (WHO). 'For over 100 years, we have relied on the BCG vaccine to protect our children from TB. But we have not had a tool that can protect adolescents and adults', he said. Motsoaledi said the day when an announcement is made on the availability of the vaccine will be a revolutionary and would be like freedom from slavery for citizens. 'The slavery of poverty, which is exacerbated by tuberculosis, premature death of young adults, people losing jobs because of tuberculosis, will come to an end', he said. Motsoaledi emphasised that the key areas that will make the system ready for implementation and rollout of the vaccine will be generating evidence for policy and investments, reliable delivery systems, and production and supply of the TB vaccine. 'These new vaccines will be a game changer for prevention and for reducing the need for TB preventive treatment in health systems', he said. Motsoaledi said the advent of Covid-19 taught the world when urgency met preparation. 'We saw how vaccines could be developed, approved and distributed at record speed but we also learnt that science alone is not enough. Public trust, strong systems, clear communication and equitable access are just as essential,' Motsoaledi said.